Deemea

📍 PARIS, France🗓 Founded 2020👥 19 employees💰 Last funded Jan 2024
Biotechnology Research
LinkedIn
Deemea is a digital health company with expertise in the AI-driven structuring and analysis of medical data. Our specialization in imaging data processing has led us to develop and deploy a collaborative platform for medical data analysis, aimed at expediting biopharmaceutical and medical device clinical studies. Our innovative proprietary technology powers a multi-modal, multi-centric platform that prioritizes the security, privacy, and sovereignty of medical data, as well as the sustainability of healthcare facilities. Deemea empowers data-driven research, ultimately expediting patients access to innovative therapies.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in Deemea?
Deemea has 1 investors on record on gritt.io, 1 mid-stage.
When did Deemea last raise funding?
The most recent investment in Deemea recorded on gritt.io was in January 2024.
When was Deemea founded?
Deemea was founded in 2020.
What industry is Deemea in?
Deemea operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Deemea based?
Deemea is headquartered in PARIS, France.